Adverum Biotechnologies SG&A Expense (TTM) Analysis

Adverum Biotechnologies Inc (ADVM)

7.53 +0.25 (+3.43%) USD | NASDAQ | Oct 04, 16:00

7.545 +0.02 (+0.20%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	39.88M
March 31, 2024	48.56M
December 31, 2023	49.92M
September 30, 2023	50.78M
June 30, 2023	54.18M
March 31, 2023	55.47M
December 31, 2022	57.86M
September 30, 2022	58.01M
June 30, 2022	55.28M
March 31, 2022	63.45M
December 31, 2021	64.44M
September 30, 2021	66.20M
June 30, 2021	63.10M
March 31, 2021	51.76M
December 31, 2020	44.64M
September 30, 2020	39.27M
June 30, 2020	35.31M
March 31, 2020	31.84M
December 31, 2019	28.38M
September 30, 2019	25.28M
June 30, 2019	22.72M
March 31, 2019	24.77M

Date	Value
December 31, 2018	24.56M
September 30, 2018	23.42M
June 30, 2018	23.35M
March 31, 2018	18.24M
December 31, 2017	20.86M
September 30, 2017	21.59M
June 30, 2017	22.98M
March 31, 2017	24.03M
December 31, 2016	24.36M
September 30, 2016	24.95M
June 30, 2016	26.44M
March 31, 2016	26.28M
December 31, 2015	22.11M
September 30, 2015	20.11M
June 30, 2015	14.88M
March 31, 2015	11.42M
December 31, 2014	7.998M
September 30, 2014	5.808M
June 30, 2014	3.668M
March 31, 2014	2.368M
December 31, 2013	1.783M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

28.38M

Minimum

Dec 2019

66.20M

Maximum

Sep 2021

50.44M

Average

51.76M

Median

Mar 2021

SG&A Expense (TTM) Benchmarks